POU5F1 and neoplasm: Although the postoperative immunohistochemistry showed (Figures 3, 4) the loss of SMARCB1/INI-1 expression and the negative expression of OCT4, considering the location of the tumor and the patient’s age, the patient still received adjuvant chemotherapy for testicular seminoma after surgery.